Close Menu

SAN FRANCISCO (GenomeWeb) – Circulating tumor DNA holds great promise as a way to molecularly profile cancer patients' tumors, to monitor their response to therapy, and to identify markers of residual or recurrent disease as well as drug resistance. One difficulty with ctDNA, however, is that any given somatic mutation is present at a very low frequency — often making true mutations difficult to distinguish from errors.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

A small study has found that a rapid test for SARS-CoV-2 works about as well as a PCR test, according to the New York Times.

New Scientist reports that a new genetic analysis suggests some saber-toothed cats may have lived in packs and been fast runners.

PLOS is piloting a new model under which research institutions pay a flat fee for its researchers to publish in its journals, Science reports.

In Science this week: honey bees recognize colony mates by their gut microbiomes, and more.

Oct
20
Sponsored by
Stilla

This webinar will discuss a new method that relies on Crystal digital PCR from Stilla Technologies to monitor chimerism in patients after stem cell transplantation, which is a key part of surveillance for impending clinical relapse.

Oct
21
Sponsored by
Roche

Target enrichment has been a major driver behind the clinical adoption of next-generation sequencing (NGS) over the last decade because it simplifies analysis and provides a cost-effective method of massive parallel resequencing. It has not only replaced Sanger sequencing, but it is actively dispensing the need for parallel copy number variant (CNV) analysis using classic techniques.

Oct
22
Sponsored by
Sophia Genetics

This webinar will share the Lorraine Cancer Institute's experience in implementing a novel targeted solution to accurately assess homologous recombination repair (HRR) deficiency by analyzing a series of genes, beyond BRCA, and calling multiple types of variants, including copy number variants (CNVs).

Oct
26
Sponsored by
Sophia Genetics

This webinar will discuss Genotypos Science Labs’ experience with a whole-exome sequencing solution supporting the detection of copy number variants (CNVs) for the management of complex cases.